Brooks O'Neil
Stock Analyst at Lake Street
(0.58)
# 4,134
Out of 5,138 analysts
34
Total ratings
26.47%
Success rate
-21.53%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.83 | +108.88% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $21.22 | -43.45% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.76 | +112.77% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $3.51 | +469.80% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $88.00 | +25.00% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $18.04 | +66.30% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $20.98 | +238.42% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $6.24 | +316.67% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $48.73 | +12.87% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $17.59 | +2.33% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $10.07 | +98.71% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.84 | +30.38% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $5.54 | +116.61% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $28.35 | -8.27% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.48 | +2,186.90% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $27.42 | +365.07% | 1 | Sep 15, 2020 |
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.83
Upside: +108.88%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $21.22
Upside: -43.45%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.76
Upside: +112.77%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $3.51
Upside: +469.80%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $88.00
Upside: +25.00%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $18.04
Upside: +66.30%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $20.98
Upside: +238.42%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $6.24
Upside: +316.67%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $48.73
Upside: +12.87%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $17.59
Upside: +2.33%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $10.07
Upside: +98.71%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.84
Upside: +30.38%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $5.54
Upside: +116.61%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $28.35
Upside: -8.27%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.48
Upside: +2,186.90%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $27.42
Upside: +365.07%